Evidence map›Paper›PMID 41555135›Full record

ArticleHealth economics2026

Medicare Part D and Hospital Admissions due to Antimicrobial Resistance.

Ricardo B Ang

Abstract read
In one paragraph

Article in Health economics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ricardo B AngDepartment of Economics and the Murphy Institute, Tulane University, New Orleans, Louisiana, USA.ORCID 0000-0002-8218-2607

Funding

Georgia State University
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) has been increasing rapidly in the United States despite government efforts to contain its spread. Both under-utilization and overuse of prescribed antimicrobials contribute to rising resistance. The introduction of Medicare Part D in 2006 expanded prescription drug coverage for the elderly, including coverage for antimicrobial medications. If cost barriers had previously led to under-utilization of prescriptions, then Medicare Part D could have mitigated AMR by improving access to antimicrobials. However, if Medicare Part D also encouraged excessive antibiotic use, it may have inadvertently contributed to greater resistance. Using data from the Nationwide Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality for January 2001 to September 2008, I estimate the causal impact of Medicare Part D on AMR-related hospital discharges using a difference-in-differences identification strategy. My findings suggest that Medicare Part D led to a slower increase in AMR-related inpatient discharges among the Medicare-eligible population.

Indexed as

Anti-Bacterial AgentsDrug Resistance, MicrobialHospitalizationMedicare Part DAgedAged, 80 and overFemaleHumansMaleUnited StatesAnti-Bacterial Agentsantimicrobial resistancedifference‐in‐differenceshospital admissionsMedicare Part Dprescription drug coverage

Identifiers

PMID41555135
PMCPMC13039772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.